Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05941637
Status:
AVAILABLE
Last Update Posted:
2023-07-12
First Post:
2023-07-03
Brief Title:
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer Ductal Papillary Chromophobic Oncocytic With Mutations in VHL PBRM1 BAP1 SETD2 VEGF
Sponsor:
Lynkcell Europe
Organization:
Lynkcell Europe
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Kidney Cancer With PBRM1BAP1VHLSETD2 Mutations |
| Clear Cell Kidney Cancer |
| Kidney Cancer |
Keywords: